299 related articles for article (PubMed ID: 35267131)
1. Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
Liang YJ
Glycoconj J; 2022 Apr; 39(2):177-195. PubMed ID: 35267131
[TBL] [Abstract][Full Text] [Related]
2. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
[TBL] [Abstract][Full Text] [Related]
3. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.
Liang YJ; Kuo HH; Lin CH; Chen YY; Yang BC; Cheng YY; Yu AL; Khoo KH; Yu J
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22564-9. PubMed ID: 21149694
[TBL] [Abstract][Full Text] [Related]
4. Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages.
Liang YJ; Yang BC; Chen JM; Lin YH; Huang CL; Cheng YY; Hsu CY; Khoo KH; Shen CN; Yu J
Stem Cells; 2011 Dec; 29(12):1995-2004. PubMed ID: 21956927
[TBL] [Abstract][Full Text] [Related]
5. Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications.
Ho MY; Yu AL; Yu J
Glycoconj J; 2017 Dec; 34(6):765-777. PubMed ID: 27549315
[TBL] [Abstract][Full Text] [Related]
6. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
[TBL] [Abstract][Full Text] [Related]
8. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
9. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
10. Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor.
Park SY; Kwak CY; Shayman JA; Kim JH
Biochim Biophys Acta; 2012 Jul; 1820(7):1141-8. PubMed ID: 22542783
[TBL] [Abstract][Full Text] [Related]
11. Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro.
Wang J; Yu RK
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19137-42. PubMed ID: 24198336
[TBL] [Abstract][Full Text] [Related]
12. Alterations of Glycosphingolipids in Embryonic Stem Cell Differentiation and Development of Glycan-Targeting Cancer Immunotherapy.
Yu AL; Hung JT; Ho MY; Yu J
Stem Cells Dev; 2016 Oct; 25(20):1532-1548. PubMed ID: 27507584
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside Microdomains on Cellular and Intracellular Membranes Regulate Neuronal Cell Fate Determination.
Itokazu Y; Yu RK
Adv Neurobiol; 2023; 29():281-304. PubMed ID: 36255679
[TBL] [Abstract][Full Text] [Related]
14. B3GALT5 knockout alters gycosphingolipid profile and facilitates transition to human naïve pluripotency.
Lin RJ; Kuo MW; Yang BC; Tsai HH; Chen K; Huang JR; Lee YS; Yu AL; Yu J
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27435-27444. PubMed ID: 33087559
[TBL] [Abstract][Full Text] [Related]
15. Changes of glycoconjugate expression profiles during early development.
Handa K; Hakomori SI
Glycoconj J; 2017 Dec; 34(6):693-699. PubMed ID: 27318475
[TBL] [Abstract][Full Text] [Related]
16. Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
Dookwah M; Wagner SK; Ishihara M; Yu SH; Ulrichs H; Kulik MJ; Zeltner N; Dalton S; Strauss KA; Aoki K; Steet R; Tiemeyer M
Hum Mol Genet; 2023 Dec; 32(24):3323-3341. PubMed ID: 37676252
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
Liu J; Zheng X; Pang X; Li L; Wang J; Yang C; Du G
Acta Pharm Sin B; 2018 Sep; 8(5):713-720. PubMed ID: 30245960
[TBL] [Abstract][Full Text] [Related]
18. Approach for Profiling of Glycosphingolipid Glycosylation by Multiplexed Capillary Gel Electrophoresis Coupled to Laser-Induced Fluorescence Detection To Identify Cell-Surface Markers of Human Pluripotent Stem Cells and Derived Cardiomyocytes.
Rossdam C; Konze SA; Oberbeck A; Rapp E; Gerardy-Schahn R; von Itzstein M; Buettner FFR
Anal Chem; 2019 May; 91(10):6413-6418. PubMed ID: 31058489
[TBL] [Abstract][Full Text] [Related]
19. TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
Dewald JH; Cavdarli S; Steenackers A; Delannoy CP; Mortuaire M; Spriet C; Noël M; Groux-Degroote S; Delannoy P
PLoS One; 2018; 13(4):e0196369. PubMed ID: 29698439
[TBL] [Abstract][Full Text] [Related]
20. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
